National Cancer Institute, Bethesda, Maryland.
Penn State College of Medicine, Hershey, Pennsylvania.
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1949-1954. doi: 10.1158/1055-9965.EPI-20-0007.
Cancer mortality is higher in counties with high levels of (current) poverty, but less is known about associations with persistent poverty. Persistent poverty counties (with ≥20% of residents in poverty since 1980) face social, structural, and behavioral challenges that may make their residents more vulnerable to cancer.
We calculated 2007 to 2011 county-level, age-adjusted, and overall and type-specific cancer mortality rates (deaths/100,000 people/year) by persistent poverty classifications, which we contrasted with mortality in counties experiencing current poverty (≥20% of residents in poverty according to 2007-2011 American Community Survey). We used two-sample tests and multivariate linear regression to assess mortality by persistent poverty, and compared mortality rates across current and persistent poverty levels.
Overall cancer mortality was 179.3 [standard error (SE) = 0.55] deaths/100,000 people/year in nonpersistent poverty counties and 201.3 (SE = 1.80) in persistent poverty counties (12.3% higher, < 0.0001). In multivariate analysis, cancer mortality was higher in persistent poverty versus nonpersistent poverty counties for overall cancer mortality as well as for several type-specific mortality rates: lung and bronchus, colorectal, stomach, and liver and intrahepatic bile duct (all < 0.05). Among counties experiencing current poverty, those counties that were also experiencing persistent poverty had elevated mortality rates for all cancer types as well as lung and bronchus, colorectal, breast, stomach, and liver and intrahepatic bile duct (all < 0.05).
Cancer mortality was higher in persistent poverty counties than other counties, including those experiencing current poverty.
Etiologic research and interventions, including policies, are needed to address multilevel determinants of cancer disparities in persistent poverty counties.
癌症死亡率在贫困水平较高的县更高,但对于与持续贫困相关的情况了解较少。持续贫困县(自 1980 年以来,有≥20%的居民处于贫困状态)面临社会、结构和行为方面的挑战,这可能使居民更容易受到癌症的影响。
我们根据持续贫困分类计算了 2007 年至 2011 年县一级、年龄调整后的、整体和特定类型的癌症死亡率(死亡/每 10 万人/年),并将其与当前贫困县(根据 2007-2011 年美国社区调查,有≥20%的居民处于贫困状态)的死亡率进行对比。我们使用两样本 t 检验和多元线性回归来评估持续贫困的死亡率,并比较了当前贫困和持续贫困水平下的死亡率。
非持续贫困县的整体癌症死亡率为 179.3[标准误差(SE)=0.55]例/每 10 万人/年,持续贫困县为 201.3(SE=1.80)例/每 10 万人/年(高 12.3%,<0.0001)。在多变量分析中,与非持续贫困县相比,持续贫困县的整体癌症死亡率以及几种特定类型的死亡率更高:肺癌和支气管癌、结直肠癌、胃癌和肝癌及肝内胆管癌(均<0.05)。在经历当前贫困的县中,那些同时经历持续贫困的县,所有癌症类型以及肺癌和支气管癌、结直肠癌、乳腺癌、胃癌和肝癌及肝内胆管癌的死亡率都更高(均<0.05)。
与其他县相比,包括经历当前贫困的县,持续贫困县的癌症死亡率更高。
需要开展病因学研究和干预措施,包括政策,以解决持续贫困县癌症差异的多层次决定因素。